ALSO NOTED: Daiichi Sankyo files supplemental NDA; BioSante launches Phase III trial; and much more...
Free newsletter via e-mail
Tools
> Daiichi Sankyo has filed a supplemental NDA with the FDA, looking for approval to use WelChol to improve glycemic control. Report
> Antares Pharma's development partner, BioSante Pharmaceuticals, has initiated a Phase III safety and efficacy trial of Antares' transdermal testosterone gel for the treatment of FSD. Release
> pSivida has been released from a loan covenant. Release
> Biomira has begun enrolling patients for a Phase II pancreatic cancer study. Release
And Finally… Dr. Gilbert Welch says that part of what afflicts Americans is an epidemic of diagnoses. Editorial
SHARE
WITH: